Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: KILITCH and BSE: 524500 (ISIN INE729D01010).
It has a market capitalisation of ₹766 crore, a last close of ₹218.98 on 2026-10-19, a one-year return of 17.3%.
Valuation: a price-to-earnings ratio of 25.47x, a price-to-book ratio of 2.74x, a dividend yield of 0.0%.
Profitability: return on equity of 12.5%, return on capital employed of 15.7%, an operating margin of 15.3%.
Growth: sales growth of 19.0% a year over three years, net profit growth of 42.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.32x, promoter holding of 63.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 766 |
| Last close | ₹218.98 |
| P/E (TTM) | 25.47x |
| P/B | 2.74x |
| Dividend yield | 0.0% |
| ROE (FY) | 12.5% |
| ROCE (FY) | 15.7% |
| Operating margin (TTM) | 15.3% |
| Sales growth, 3-year CAGR | 19.0% |
| Profit growth, 3-year CAGR | 42.4% |
| Debt / equity | 0.32x |
| Promoter holding | 63.8% |
| 1-year return | 17.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means